IDYA Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-19 | 2023 | Andres Ruiz Briseno | 345,000 | 0 | 0 | 125,125 | 15,000 | 1,412,542 |
| 2024-04-19 | 2023 | Yujiro S. Hata President and Chief Executive Officer | 598,000 | 0 | 0 | 299,000 | 15,000 | 5,995,440 |
| 2024-04-19 | 2023 | Michael A. White, Ph.D. Chief Scientific Officer | 462,000 | 0 | 0 | 184,800 | 15,000 | 2,758,719 |
| 2024-04-19 | 2023 | Jason S. Throne | 417,000 | 0 | 0 | 166,800 | 15,000 | 1,869,660 |
| 2024-04-19 | 2022 | Darrin M. Beaupre, MD., Ph.D. Chief Medical Officer | 52,487 | 100,000 | 0 | 0 | 150 | 2,532,759 |
| 2024-04-19 | 2023 | Darrin M. Beaupre, MD., Ph.D. Chief Medical Officer | 473,000 | 0 | 0 | 189,200 | 3,377 | 1,809,351 |
| 2024-04-19 | 2022 | Yujiro S. Hata President and Chief Executive Officer | 570,000 | 0 | 0 | 270,750 | 10,950 | 3,327,004 |
| 2024-04-19 | 2022 | Paul A. Stone. Former Chief Financial Officer | 419,000 | 0 | 0 | 161,734 | 10,950 | 1,472,321 |
| 2024-04-19 | 2023 | Paul A. Stone. Former Chief Financial Officer | 432,024 | 0 | 0 | 0 | 14,775 | 2,226,003 |
| 2024-04-19 | 2022 | Michael A. White, Ph.D. Chief Scientific Officer | 440,000 | 0 | 0 | 169,840 | 4,009 | 1,494,486 |
| 2023-04-14 | 2021 | Michael White, Ph.D. Chief Scientific Officer | 80,625 | 180,000 | 0 | 0 | 375 | 3,582,860 |
| 2023-04-14 | 2022 | Yujiro S. Hata President and Chief Executive Officer | 570,000 | 0 | 0 | 270,750 | 10,950 | 3,327,004 |
| 2023-04-14 | 2021 | Yujiro S. Hata President and Chief Executive Officer | 543,600 | 0 | 0 | 244,620 | 10,500 | 3,848,871 |
| 2023-04-14 | 2022 | Darrin M. Beaupre, MD., Ph.D. | 52,487 | 100,000 | 0 | 0 | 150 | 2,532,759 |
| 2023-04-14 | 2022 | Michael White, Ph.D. Chief Scientific Officer | 440,000 | 0 | 0 | 169,840 | 4,009 | 1,494,486 |
| 2022-04-26 | 2021 | Yujiro S. Hata President and Chief Executive Officer | 543,600 | 0 | 0 | 244,620 | 10,500 | 3,848,871 |
| 2022-04-26 | 2020 | Yujiro S. Hata President and Chief Executive Officer | 509,800 | 0 | 0 | 191,175 | 10,350 | 1,777,811 |
| 2022-04-26 | 2021 | Paul A. Stone, J.D. Senior Vice President and Chief Financial Officer | 394,000 | 0 | 0 | 146,940 | 10,500 | 1,802,784 |
| 2022-04-26 | 2020 | Paul A. Stone, J.D. Senior Vice President and Chief Financial Officer | 374,500 | 0 | 0 | 123,585 | 10,350 | 905,267 |
| 2022-04-26 | 2021 | Michael White, Ph.D. ( 5) | 80,625 | 180,000 | 0 | 0 | 375 | 3,582,860 |
| 2022-04-26 | 2021 | Michael Dillon, Ph.D. ( 6) Former Senior Vice President and Chief Scientific Officer, Head of Research | 385,768 | 0 | 0 | 0 | 379,100 | 2,016,212 |
| 2022-04-26 | 2020 | Michael Dillon, Ph.D. ( 6) Former Senior Vice President and Chief Scientific Officer, Head of Research | 371,000 | 0 | 0 | 122,430 | 1,800 | 805,255 |
| 2021-04-19 | 2020 | Jason S. Throne, J.D. ( 4) | 332,500 | 0 | 0 | 89,513 | 3,550 | 1,163,796 |
| 2021-04-19 | 2019 | Paul A. Stone, J.D. Senior Vice President and Chief Financial Officer | 327,250 | 0 | 0 | 103,000 | 1,800 | 613,014 |
| 2021-04-19 | 2020 | Paul A. Stone, J.D. Senior Vice President and Chief Financial Officer | 374,500 | 0 | 0 | 123,585 | 10,350 | 905,267 |
| 2021-04-19 | 2019 | Yujiro S. Hata President and Chief Executive Officer | 457,150 | 0 | 0 | 154,943 | 10,200 | 2,020,989 |
| 2021-04-19 | 2020 | Yujiro S. Hata President and Chief Executive Officer | 509,800 | 0 | 0 | 191,175 | 10,350 | 1,777,811 |
| 2020-04-27 | 2018 | Michael Dillon, Ph.D. Senior Vice President and Chief Scientific Officer, Head of Research | 315,000 | 0 | 0 | 94,500 | 4,506 | 658,045 |
| 2020-04-27 | 2019 | Yujiro Hata President and Chief Executive Officer | 457,150 | 0 | 0 | 154,943 | 10,200 | 2,020,989 |
| 2020-04-27 | 2019 | Michael Dillon, Ph.D. Senior Vice President and Chief Scientific Officer, Head of Research | 338,875 | 0 | 0 | 95,500 | 10,200 | 670,780 |
| 2020-04-27 | 2018 | Julie Hambleton, M.D. Senior Vice President and Chief Medical Officer, Head of Development | 218,750 | 0 | 0 | 65,625 | 1,050 | 797,642 |
| 2020-04-27 | 2019 | Julie Hambleton, M.D. Senior Vice President and Chief Medical Officer, Head of Development | 387,063 | 0 | 0 | 108,500 | 10,200 | 686,726 |
| 2020-04-27 | 2018 | Yujiro Hata President and Chief Executive Officer | 420,000 | 0 | 0 | 147,000 | 8,000 | 2,262,701 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
